Effective Role of Hormonal Therapy in Metastatic Primary Neuroendocrine Breast Carcinoma

被引：15
|
作者：
Buttar, Amanpreet [1 ]
Mittal, Kriti [2 ]
Khan, Ashraf [1 ]
Bathini, Venu [1 ]
机构：
[1] UMass Mem Med Ctr, Dept Hematol Oncol, Worcester, MA 01655 USA
[2] St Vincent Hosp, Dept Internal Med, Worcester, MA 01604 USA
来源：
CLINICAL BREAST CANCER | 2011年 / 11卷 / 05期
关键词：
FEATURES;
D O I：
10.1016/j.clbc.2011.02.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Primary neuroendocrine carcinoma (PNEC) of the breast is extremely rare.(1) Because of the rarity of this cancer, long-term prognosis, biologic behavior, and treatment are not well known. PNEC can have high expression of estrogen receptor (ER) and progesterone receptor (PR). It is important to differentiate PNEC of the breast from other metastatic diseases to the breast because of the differences in treatment. We herein report the successful treatment of a patient with PNEC of the breast and high expression of ER and PR by means of hormonal therapy.
引用
收藏
页码：342 / 345
页数：4
相关论文
共 50 条
  • [1] Does Hormonal Therapy Have a Therapeutic Role in Metastatic Primary Small Cell Neuroendocrine Breast Carcinoma? Case Report and Literature Review
    Alkaied, Homam
    Harris, Kassem
    Brenner, Arnold
    Awasum, Michael
    Varma, Seema
    CLINICAL BREAST CANCER, 2012, 12 (03) : 226 - 230
  • [2] Primary Neuroendocrine Carcinoma of the Breast Metastatic to the Bones, Which Chemotherapy?
    Soe, Aye M.
    Joseph, Gardith
    Guevara, Elizabeth
    Xiao, Philip
    BREAST JOURNAL, 2017, 23 (05): : 589 - 593
  • [3] Neuroendocrine carcinoma metastatic to the breast
    Hwang, Helena
    Hou, Karen T.
    Schiller, Carol L.
    Wayne, Jeffrey D.
    Mendelson, Ellen B.
    Susnik, Barbara
    BREAST JOURNAL, 2008, 14 (02): : 201 - 202
  • [4] Solitary Neuroendocrine Breast Mass: Primary Mammary Carcinoma or Metastatic Disease?
    Pamudurthy, V.
    Abraham, R. Z.
    Alam, B.
    Betlej, T.
    Sipahi, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [5] Primary neuroendocrine breast carcinoma or metastatic lung cancer? The role of a careful interpretation of GATA-3
    Caschili, J.
    Ravarino, A.
    Nonnis, L.
    Murru, R.
    Gerosa, C.
    Faa, G.
    Fanni, D.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S196 - S196
  • [6] HORMONAL TREATMENT OF METASTATIC CARCINOMA OF THE BREAST
    BAKER, WH
    KELLEY, RM
    SOHIER, WD
    AMERICAN JOURNAL OF SURGERY, 1960, 99 (04): : 538 - 543
  • [7] RANDOMIZED SEQUENTIAL HORMONAL THERAPY VS ADRENALECTOMY FOR METASTATIC BREAST CARCINOMA
    YONEMOTO, RH
    TAN, MSC
    BYRON, RL
    RIIHIMAKI, DU
    KEATING, J
    JACOBS, W
    CANCER, 1977, 39 (02) : 547 - 555
  • [8] Primary Neuroendocrine Breast Carcinoma
    Menendez, Pablo
    Garcia, Esther
    Rabadan, Lorenzo
    Pardo, Ricardo
    Padilla, David
    Villarejo, Pedro
    CLINICAL BREAST CANCER, 2012, 12 (04) : 300 - 303
  • [9] Primary Neuroendocrine Carcinoma of The Breast
    Cinkir, Havva Y.
    Demirci, Umut
    Helvaci, Kaan
    Bal, Oznur
    Demirci, Ayse
    Alkis, Necati
    Oksuzoglu, Berna
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2014, 24 (04): : 281 - 283
  • [10] Primary neuroendocrine carcinoma of the breast
    Bergstrom, Colin
    Porembka, Jessica
    Fang, Yisheng
    Sarode, Venetia
    Syed, Samira
    BREAST JOURNAL, 2019, 25 (03): : 519 - 520
12345